Health AI Central
Share:
Peer-Reviewed Publication
Diabetes Obes Metab2025;27(2):1018-1020.February 1, 2025Letter

Future directions for quality of life research with second-generation GLP-1RAs for obesity.

Robert Hsu1, Tejaswi Kompala1,2, Anne-Kathrin Eiselt1
1Teladoc Health, Purchase, New York, USA.
2University of Utah Health, Salt Lake City, Utah, USA.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.